Skip to content
10-Q

Quarterly Report

KYTHERA BIOPHARMACEUTICALS INC

0001558370-15-001486

← back to feed
Filed
Aug 6, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · Jul 27, 2015 26.27M sh
Capex Q2 2015 · Jun 30, 2015 $587K
Capex Q2 2015 · Jun 30, 2014 $791K
Cash And Equivalents Q2 2015 · Jun 30, 2015 $92.31M
Cash And Equivalents Q2 2015 · Dec 31, 2014 $29.23M
Cash And Equivalents Q2 2015 · Jun 30, 2014 $83.61M
Cash And Equivalents Q2 2015 · Dec 31, 2013 $111.52M
Stockholders Equity Q2 2015 · Jun 30, 2015 $146.49M
Stockholders Equity Q2 2015 · Dec 31, 2014 $59.44M
Current Liabilities Q2 2015 · Jun 30, 2015 $23.68M
Current Liabilities Q2 2015 · Dec 31, 2014 $20.63M
Total Liabilities Q2 2015 · Jun 30, 2015 $48.96M
Total Liabilities Q2 2015 · Dec 31, 2014 $43.99M
Current Assets Q2 2015 · Jun 30, 2015 $192.48M
Current Assets Q2 2015 · Dec 31, 2014 $101.16M
Total Assets Q2 2015 · Jun 30, 2015 $195.45M
Total Assets Q2 2015 · Dec 31, 2014 $103.43M
Sga Expense Q2 2015 · Jun 30, 2015 $24.98M
Sga Expense Q2 2015 · Jun 30, 2015 $37.47M
Sga Expense Q2 2015 · Jun 30, 2014 $7.36M
Sga Expense Q2 2015 · Jun 30, 2014 $13.49M
Rd Expense Q2 2015 · Jun 30, 2015 $11.23M
Rd Expense Q2 2015 · Jun 30, 2015 $26.49M
Rd Expense Q2 2015 · Jun 30, 2014 $10.96M
Rd Expense Q2 2015 · Jun 30, 2014 $20.94M
Net Income Q2 2015 · Jun 30, 2015 −$37.15M
Net Income Q2 2015 · Jun 30, 2015 −$65.97M
Net Income Q2 2015 · Jun 30, 2014 −$19.48M
Net Income Q2 2015 · Jun 30, 2014 −$88.93M
Operating Income Q2 2015 · Jun 30, 2015 −$35.93M
Operating Income Q2 2015 · Jun 30, 2015 −$63.69M
Operating Income Q2 2015 · Jun 30, 2014 −$18.33M
Operating Income Q2 2015 · Jun 30, 2014 −$87.18M
Cost Of Revenue Q2 2015 · Jun 30, 2015 $14K
Cost Of Revenue Q2 2015 · Jun 30, 2015 $14K